Showing results (1131-1140 of 1,201) with videos related to

Sort By:
Pageof 121
Annals of Surgery|June 21, 2024
The Prognostic Impact of Minimally Invasive Esophagectomy on Survival After Esophagectomy Following a Delayed Interval After Chemoradiotherapy: A Secondary Analysis of the DICE StudySheraz R Markar, Bruno Sgromo, Richard Evans, et al.
Oncoimmunology|July 20, 2023
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibitionTom van den Ende, Aiarpi Ezdoglian, Lisanne M Baas, et al.
Annals of Surgery|November 22, 2023
Evolution in Laparoscopic Gastrectomy From a Randomized Controlled Trial Through National Clinical PracticeSheraz R Markar, Maurits R Visser, Arjen van der Veen, et al.
Annals of Surgery|August 7, 2024
Optimal Treatment Strategies for cT2 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A Multinational, High-volume Center Retrospective Cohort AnalysisNaita M Wirsik, Cezanne D Kooij, Niall Dempster, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 18, 2023
Pain and Opioid Consumption After Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Secondary Analysis of a Multicenter Randomized Clinical Trial (LOGICA-Trial)Arjen van der Veen, Mark Ramaekers, Marije Marsman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using <sup>18</sup>F-FDG PET/CT and DW-MRI: A Prospective Multicenter StudyAlicia S Borggreve, Lucas Goense, Peter S N van Rossum, et al.
The Lancet. Oncology|June 5, 2018
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort studyBo Jan Noordman, Manon C W Spaander, Roelf Valkema, et al.
Annals of Surgical Oncology|October 14, 2025
Comparison of Pretreatment Strategies for cT2cN0 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A European High-Volume Center Cohort AnalysisNaita M Wirsik, Thomas Schmidt, Cezanne D Kooij, et al.
Cancers|June 10, 2023
Prognostic Value of [Lieke C E Pullen, Wyanne A Noortman, Lianne Triemstra, et al.
BMC Cancer|March 18, 2014
Imagine a world without cancerBjörn L D M Brücher, Gary Lyman, Richard van Hillegersberg, et al.
Pageof 121